A new report suggests ways policy makers can support and advance value-based payment models so payment innovations can catch up to healthcare delivery innovations.
As the United States innovates its healthcare delivery system with features like case management and telehealth, it runs into the challenge of payment innovations that have not kept pace. A new primer from the Council of Accountable Physician Practice (CAPP) outlines a roadmap to transition from a fee-for-service system to one that pays for value. The primer is the third in the Implementing Health System Improvement series.
The report suggests ways policy makers can advance value-based payments even as most attention is focused on changes to insurance coverage.
“Value-based payment systems hold providers accountable for improving people’s health, not simply doing more procedures,” CAPP Chairman Stephen Parodi, MD, associate executive director, The Permanente Medical Group, said in a statement. “Value-based payment lets us step back and look at patterns of care over time, so that we can change our processes to improve quality and efficiency. It allows us to achieve true innovative solutions for delivering care that is coordinated, cutting edge, convenient, and most importantly, producing ever better health outcomes.”
In presenting lessons learned from value-based payments, the primer identifies the challenges associated bundled payments and accountable care organizations (ACOs).
For example, while bundled payments encourage providers to manage episodes in the most efficient way, they should only be used for patients requiring well-defined, time-limited episodes of care or procedures. In contrast, bundled payments “are not an ideal payment mechanism for care that is both complex and ongoing,” the report noted.
In comparison to bundled payments, ACOs incentivize providers to meet budget and quality targets for whole populations, which makes them more appropriate for caring for patients with chronic disease. ACOs have their own issues.
“While we see great potential in these models, we have been challenged by several issues, including patient attribution methods, data lags, and, in some cases, unrealistic financial models using historic cost trends that ultimately penalize us for previous inefficiencies,” according to the report.
With the acknowledgement of the opportunities and challenges in value-based payment models, the primer offers several recommendations for policy makers to continue supporting value-based payment programs:
CMS released a final rule to help patients obtain Children’s Health Insurance Program (CHIP) coverage and issued a proposed rule to update Medicare payment policies and rates for inpatient rehabilitation facilities; debate over if gift card incentives are acceptable in health care marketing.
Read More
Exploring Medicare Advantage Prior Authorization Variations
March 26th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the March 2024 issue of The American Journal of Managed Care® about their findings on variations in prior authorization use across Medicare Advantage plans.
Listen
A global AIDS program that was in limbo for months got temporary relief after congressional negotiators agreed to a 1-year renewal in the next government funding package; the outcome of the November presidential election could determine the state of fetal tissue research in the US; federal officials and industry executives failed to make improvements that stop hacking attacks.
Read More
Navigating Health Literacy, Social Determinants, and Discrimination in National Health Plans
February 13th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the February 2024 issue of The American Journal of Managed Care® about their findings on how health plans can screen for health literacy, social determinants of health, and perceived health care discrimination.
Listen
Fragmented Payer System, Vulnerable Supply Chain Among Threats to Accessing Essential Medicines
March 13th 2024During a session of the 2024 V-BID Summit, panelists Stacie Dusetzina, PhD, and Inma Hernandez, PharmD, PhD, discussed how access to essential medications is curtailed not just by the longstanding complexities of insurance design but also by emerging threats such as supply chain weaknesses and cyberattacks.
Read More
Most private health insurers have yet to publish criteria for when they will cover postpartum depression drug, zuranolone; state lawmakers are increasingly opposing health care mergers that they believe do not serve the public interest; Medicaid extensions made in 2021 led to a 40% decline in postpartum lack of insurance.
Read More